<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00689949</url>
  </required_header>
  <id_info>
    <org_study_id>144-08</org_study_id>
    <nct_id>NCT00689949</nct_id>
  </id_info>
  <brief_title>Validation of Urinary Biomarkers of Folate Status</brief_title>
  <official_title>Determination of the Suitability of Urinary Total P-aminobenzoylglutamate (p-ABG)and Formiminoglutamate (FIGLU) as a Markers for Folate Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The major objective of the proposed study is to demonstrate the suitability of new markers&#xD;
      for folate status in humans, which avoid blood sampling, as required for the established&#xD;
      marker RBC folate concentration, but can be obtained from spot urine samples. For this reason&#xD;
      urine and blood will be collected from volunteers, twice at baseline and in a subgroup after&#xD;
      6 and 12 weeks of intake of a folic acid supplement&#xD;
&#xD;
      Specific hypotheses to be tested:&#xD;
&#xD;
      Correlation study:&#xD;
&#xD;
        -  The 24 h urinary excretion of total p-ABG, as extrapolated via urinary creatinine&#xD;
           concentration from the total p-ABG concentration in a spot sample is significantly&#xD;
           correlated to RBC and plasma folate levels in the studied subjects&#xD;
&#xD;
        -  The 24 h urinary excretion of FIGLU, as extrapolated via urinary creatinine&#xD;
           concentration form the FIGLU concentration in a spot sample is significantly correlated&#xD;
           to RBC and plasma folate levels in the studied subjects&#xD;
&#xD;
      Intervention study:&#xD;
&#xD;
      Changes in folate status (RBC folate) after supplementary intake of folate result in&#xD;
      increased urinary excretion of total p-ABG and FIGLU in subjects identified with a low folate&#xD;
      status and in subjects identified with a high folate status among the study participants of&#xD;
      the correlation study&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between red blood cell folic acid concentration and urinary excretion of total p-aminobenzoylglutamate</measure>
    <time_frame>study day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between red blood cell folic acid concentration and urinary excretion of total p-aminobenzoylglutamate</measure>
    <time_frame>study day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between red blood cell folic acid concentration and urinary excretion of total p-aminobenzoylglutamate</measure>
    <time_frame>study day 84</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>folic acid</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <description>0.4 mg of folic acid per day</description>
    <arm_group_label>folic acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age: 18 - 45 years&#xD;
&#xD;
          -  apparently healthy&#xD;
&#xD;
          -  normal results on haematologic pattern and blood chemistry tests (according to&#xD;
             university hospital reference values)&#xD;
&#xD;
          -  plasma vitamin B12 &gt; 160 pmol/l&#xD;
&#xD;
          -  no diagnosis of intestinal, renal or thyroid disease (self reported)&#xD;
&#xD;
          -  only male subjects will be enrolled but regular consumption of vitamin supplements&#xD;
             (including folate) is not an exclusion criterium, as we aim to cover a wide range of&#xD;
             folate concentrations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  recent (3 months) treatment with medication, assumed to interfere with folate status&#xD;
&#xD;
          -  abuse of alcohol or drugs&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Koletzko, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haunersche Kinderklinik, Ludwig-Maximilians-University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haunersche Kinderklinik</name>
      <address>
        <city>Muenchen</city>
        <zip>D80337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <study_first_submitted>May 30, 2008</study_first_submitted>
  <study_first_submitted_qc>May 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2008</study_first_posted>
  <last_update_submitted>December 21, 2012</last_update_submitted>
  <last_update_submitted_qc>December 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2012</last_update_posted>
  <responsible_party>
    <name_title>Head of the Department for Nutrition and Metabolic Diseases</name_title>
    <organization>Haunersche Kinderklinik, Ludwig-Maximilians-University</organization>
  </responsible_party>
  <keyword>folic acid</keyword>
  <keyword>folate</keyword>
  <keyword>p-aminobenzoylglutamate</keyword>
  <keyword>formiminoglutamate</keyword>
  <keyword>homocysteine</keyword>
  <keyword>experimental validation of a new biomarker</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

